(Q33406141)

26 July 2017

title

Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia (English)

1 reference

26 July 2017

1 reference

S Sainio

1

1 reference

26 July 2017

K Javela

series ordinal

2

1 reference

26 July 2017

J Tuimala

series ordinal

3

1 reference

26 July 2017

S Koskinen

series ordinal

4

1 reference

26 July 2017

publication date

1 March 2013

1 reference

26 July 2017

1 reference

26 July 2017

volume

23

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

114-120

1 reference

Collaborative study to establish the first international standard for quantitation of anti-HPA-1a

26 July 2017

cites work

1 reference

Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia

21 January 2018

1 reference

Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia

21 January 2018

1 reference

Interlaboratory workshop on anti-HPA-1a alloantibody quantification with the mAb-specific immobilization of platelet antigen technique.

21 January 2018

1 reference

Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT).

21 January 2018

1 reference

The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia - Where does it stand?

21 January 2018

1 reference

A Simple Immunofluorescence Test for the Detection of Platelet Antibodies

21 January 2018

1 reference

Fetal thrombocytopenia and its relation to maternal thrombocytopenia

21 January 2018

1 reference

Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia

21 January 2018

1 reference

Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia

21 January 2018

1 reference

Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus

21 January 2018

1 reference

Monitoring anti-HPA-1a platelet antibody levels during pregnancy using the MAIPA test

21 January 2018

1 reference

HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia

21 January 2018

1 reference

Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions

21 January 2018

1 reference

Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study

21 January 2018

1 reference

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

21 January 2018

1 reference

Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?

21 January 2018

1 reference

348 cases of suspected neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?

21 January 2018

1 reference

Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology

21 January 2018

1 reference

Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective

21 January 2018

1 reference

Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective

21 January 2018

1 reference

Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TME.12018

1 reference

26 July 2017

1 reference